Literature DB >> 3368019

The handling of five amines by the extraneuronal deaminating system of the rat heart.

M Grohmann1, U Trendelenburg.   

Abstract

The handling of five amines by the extraneuronal deaminating system was studied in perfused hearts of rats (pretreated with reserpine; COMT and neuronal uptake inhibited). Hearts were perfused with 50 nmol/l 3H-noradrenaline for 30 min, in the presence of increasing concentrations of unlabelled (-)-adrenaline, (-)-noradrenaline, dopamine, tyramine and 5-HT. IC50's were determined as those concentrations of unlabelled amines which halved the steady-state rate of deamination of 3H-noradrenaline. After correction for changes in the tissue/medium ratio for 3H-noradrenaline, "half-saturating outside concentrations" were obtained. They increased in the order (-)-adrenaline (15 mumol/l) - tyramine - dopamine - noradrenaline - 5-HT (53 mumol/l). The Vmax for extraneuronal deamination was determined for 3H-(-)-adrenaline, 3H-(-)-noradrenaline and 3H-dopamine, as well as (by HPLC and electrochemical detection) for tyramine and 5-HT. It was low for (-)-adrenaline, intermediate for (-)-noradrenaline, dopamine and 5-HT, high for tyramine. For the three catecholamines the half-saturating outside concentrations of the extraneuronal deaminating system clearly exceeded those for the extraneuronal O-methylating system of the same organ (see Grohmann and Trendelenburg 1985), although the two enzymes appear to co-exist in the same cells, so that the same transport system is involved.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3368019     DOI: 10.1007/bf00169243

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  The kinetic constants for the extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.

Authors:  E R Fiebig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

2.  Monoamine oxidase A and B: a useful concept?

Authors:  T J Mantle; K F Tipton
Journal:  Biochem Pharmacol       Date:  1978-01-01       Impact factor: 5.858

3.  The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart.

Authors:  M Grohmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

4.  The neuronal and extraneuronal uptake and metabolism of 3H-(-)-noradrenaline in the perfused rat heart.

Authors:  E R Fiebig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

5.  The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: A novel catechol amine uptake process.

Authors:  L L Iversen
Journal:  Br J Pharmacol Chemother       Date:  1965-08

6.  The substrate specificity of uptake2 in the rat heart.

Authors:  M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

7.  The handling of five catecholamines by the extraneuronal O-methylating system of the rat heart.

Authors:  M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

8.  The influence of inhibition of catechol-O-methyl transferase or of monoamine oxidase on the extraneuronal metabolism of 3H-(-)-noradrenaline in the rat heart.

Authors:  U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

9.  The rate constants for the efflux of deaminated metabolites of 3H-dopamine from the perfused rat heart.

Authors:  H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

  9 in total
  1 in total

1.  Evidence for saturation of catechol-O-methyltransferase by low concentrations of noradrenaline in perfused lungs of rats.

Authors:  L J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.